Cart
sales@molnova.com
ML-210
CAS No. 1360705-96-9
ML-210( ML 210 | ML210 )
Catalog No. M11484 CAS No. 1360705-96-9
A small-molecule probe that selectively kills cells induced to express mutant RAS; inhibits BJeLR (expressing HRAS G12V) cell lines with IC50 of 25 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | Get Quote |
|
| 5MG | 71 | Get Quote |
|
| 10MG | 129 | Get Quote |
|
| 25MG | 233 | Get Quote |
|
| 50MG | 393 | Get Quote |
|
| 100MG | 566 | Get Quote |
|
| 200MG | 803 | Get Quote |
|
| 500MG | 1188 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameML-210
-
NoteResearch use only, not for human use.
-
Brief DescriptionA small-molecule probe that selectively kills cells induced to express mutant RAS; inhibits BJeLR (expressing HRAS G12V) cell lines with IC50 of 25 nM.
-
DescriptionA small-molecule probe that selectively kills cells induced to express mutant RAS; inhibits BJeLR (expressing HRAS G12V) cell lines with IC50 of 25 nM, displays 23-fold sensitivity over BJeH-LT (isogenic to BJeLR without HRAS G12V) cell lines; a useful tool for identifying oncogene-specific pathways and targets in cancer cells.
-
In Vitro——
-
In Vivo——
-
SynonymsML 210 | ML210
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
RecptorRas
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1360705-96-9
-
Formula Weight475.32
-
Molecular FormulaC22H20Cl2N4O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (52.60 mM)
-
SMILESO=C(N1CCN(C(C2=CC=C(Cl)C=C2)C3=CC=C(Cl)C=C3)CC1)C4=NOC(C)=C4[N+]([O-])=O
-
Chemical Name(4-(bis(4-chlorophenyl)methyl)piperazin-1-yl)(5-methyl-4-nitroisoxazol-3-yl)methanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. We?wer M, et al. Bioorg Med Chem Lett. 2012 Feb 15;22(4):1822-6.
molnova catalog
related products
-
K-Ras G12C-IN-4
K-Ras G12C-IN-4 is a potent co-valent Inhibitor of KRAS G12C.
-
KRAS inhibitor 11
KRAS inhibitor 11 is a first-in-class, high-affinity, noncovalent allosteric KRAS inhibitor.
-
BI-3406
BI-3406 is an orally active, highly potent and selective between KRAS and Son of Sevenless 1 (SOS1) interaction inhibitor(IC50 : 6 nM),with anticancer activity.
